Method of treating major depressive disorder Grant US-11957645-B2 United States of America 16 Apr 2024
Method of treating major depressive disorder Grant US-11865088-B2 United States of America 09 Jan 2024
Extended release pharmaceutical formulation and methods of treatment Grant US-11471415-B2 United States of America 18 Oct 2022
Extended release pharmaceutical formulation and methods of treatment Grant US-11471416-B2 United States of America 18 Oct 2022
Method of treating major depressive disorder Grant US-11253487-B2 United States of America 22 Feb 2022
Extended release pharmaceutical formulation Grant US-11045424-B2 United States of America 29 Jun 2021
Extended release pharmaceutical formulation Grant US-10869838-B2 United States of America 22 Dec 2020
Extended release pharmaceutical formulation Grant US-10744094-B2 United States of America 18 Aug 2020
ESKETAMINE FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER Application WO-2020075134-A1 World Intellectual Property Organisation (WIPO) 16 Apr 2020
DOSAGE REGIME OF ESKETAMINE FOR TREATING MAJOR DEPRESSIVE DISORDER Application WO-2020070547-A1 World Intellectual Property Organisation (WIPO) 09 Apr 2020
Extended release pharmaceutical formulation Grant US-10441544-B2 United States of America 15 Oct 2019